What are the benefits of bypass surgery compared to angioplasty in patients with multivessel coronary disease?
The Bypass Angioplasty Revascularization Investigation (BARI) Investigators found that after 5 years of follow-up, bypass surgery was associated with better outcomes in terms of mortality and reduced rates of myocardial infarction and repeat revascularization compared to angioplasty in patients with multivessel coronary disease. Furthermore, the CABRI Trial Participants found that bypass surgery was associated with improved survival rates compared to angioplasty in patients with multivessel coronary disease after 1 year of follow-up. Therefore, bypass surgery appears to be a more beneficial treatment than angioplasty for patients with multivessel coronary disease. 